Tuesday, May 22, 2018 10:04:16 AM
For the period ending Sept 30, 2017, the company reported $13.5M in cash and cash equivalents, with accounts payable of $125K, giving them $13.4M dollar bills left to spend.
For the period ending Dec 31, 2017, the company reported $12M of cash and cash equivalents, with accounts payable of $100K, leaving them with $12M dollar bills to spend.
For their recent reporting period discussed in the PR, ending March 31, 2018, the company reported cash and cash equivalents of $10.6M and accounts payable of $2.3M, leaving $8.3M dollars to spend.
Hence, the company's available cash dwindled by $1.4M in the 3 months between Sept 31 and Dec 31, but by almost $4M during the 3 months of the last reporting period.
If the reduction in available cash continues at the same rate as in the last reporting period, say $1M/month, they would have $6M to spend at the end of this month, and $0 by the end of Nov 2018.
For the past year, the company has been trying to raise cash, as indicated by their claim in all their SEC filings: "The Company has engaged investment banks to advise it as to raising further funding as the Company progresses towards human clinical trials."
Yet, the company has so far failed to raise a single penny. Certainly not the rosy picture painted in the PR.
A casual stroll through the lunatic asylum shows that faith does not prove anything. Friedrich Nietzsche
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM